Firefly Neuroscience (AIFF) Director Stella Vnook Receives Award

What Happened
Stella Vnook, a director of Firefly Neuroscience, was granted 84,033 deferred stock units (DSUs) on September 25, 2026. The Form 4 reports the acquisition as a derivative award (transaction code A) at $0.00 per unit — meaning no cash was paid at grant. Each DSU is a contingent right to receive one share of the company’s common stock, and the DSUs vest quarterly over a 12‑month period per the footnote.

Key Details

• Transaction date: September 25, 2026; Form 4 filed September 29, 2026 (filed within the two business‑day window — timely).
• Reported transaction: 84,033 DSUs granted, acquisition code A, reported price $0.00.
• Vesting: Quarterly vesting over a 12‑month period (four vesting events), per filing footnote.
• Nature of award: DSUs are deferred — each represents a contingent right to one share upon vesting; no immediate shares were issued or sold.
• Shares owned after transaction: Not specified in the filing.
• No tax‑withholding, 10b5‑1, or late‑filing issues are reported in this filing.

Context
Deferred stock units are a form of compensation that vests over time and do not represent immediate share purchases or sales. Grants to directors are common and are typically part of ongoing compensation or retention programs; they should be viewed differently from open‑market purchases (which may signal a director’s immediate buying conviction).